Clinical

Dataset Information

0

Phase 2 Study of DKN-01 in Colorectal Cancer


ABSTRACT: This is a Phase 2 randomized, open-label, two-part, multicenter study with a safety run-in to evaluate efficacy and safety of DKN-01 plus FOLFIRI/FOLFOX and bevacizumab versus standard of care (SOC) [FOLFIRI/FOLFOX and bevacizumab] as second-line treatment of advanced CRC patients.

DISEASE(S): Colorectal Adenocarcinoma,Colorectal Cancer,Colorectal Cancer Metastatic,Colorectal Neoplasms,Colo-rectal Cancer

PROVIDER: 2743466 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2011-03-25 | GSE21228 | GEO
2024-08-26 | GSE275628 | GEO
2023-09-01 | E-MTAB-12947 | biostudies-arrayexpress
2017-08-17 | GSE72969 | GEO
2017-08-17 | GSE72968 | GEO
2017-02-09 | GSE59077 | GEO
2017-12-31 | E-MTAB-2844 | biostudies-arrayexpress
2023-07-20 | GSE232525 | GEO
2023-09-01 | E-MTAB-12948 | biostudies-arrayexpress
2023-09-01 | E-MTAB-12951 | biostudies-arrayexpress